A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Alone or in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma
Clinical trial NCT04728321 · COMPLETED
Trial details
- NCT number
- NCT04728321
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-27
- Primary completion
- 2022-08-02
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.